Low dose naltrexone: Effects on medication in rheumatoid and seropositive arthritis. A nationwide register-based controlled quasi-experimental before-after study

PLoS One
14 February 2019
https://pubmed.ncbi.nlm.nih.gov/30763385/

Low Dose Naltrexone Easing Pain from Fibromyalgia and Other Painful Conditions

Birmingham Medical News
18 June 2019
https://www.birminghammedicalnews.com/news.php?viewStory=3241

Sjogren's Syndrome: Clinical Benefits of Low-dose Naltrexone Therapy

Cureus
11 March 2019
https://pubmed.ncbi.nlm.nih.gov/31123647/

Correction: Low dose naltrexone: Effects on medication in rheumatoid and seropositive arthritis. A nationwide register-based controlled quasi-experimental before-after study

PLoS One
01 Oct 2019
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6772034/

This corrects the article "Low dose naltrexone: Effects on medication in rheumatoid and seropositive arthritis. A nationwide register-based controlled quasi-experimental before-after study" in volume 14, e0212460.

Bernard Bihari, MD: Low-Dose Naltrexone for normalizing immune system function

Altern Ther Health Med
05 November 2013
http://todayspractitioner.com/wp-content/uploads/2013/10/Bernard-Bihari-MD-Low-dose-Naltrexone-for-Normalizing-Immune-System-Function-athm_19_2_bihari_56_65.pdf

The Uses of Low-Dose Naltrexone in Clinical Practice

BMJ Case Reports
January 2018
https://www.researchgate.net/publication/328997819_Issue_4_The_Uses_of_Low-Dose_Naltrexone_in_Clinical_Practice

The Benefits of Low Dose Naltrexone

JewishLink
21 May 2020
https://jewishlink.news/monthly-sections/health-link-new/37942-the-benefits-of-low-dose-naltrexone

Sarah Zielsdorf, MD, MS - Rheumatoid Arthritis (2018 Conference) (LDN, low dose naltrexone)

Dr Sarah Zielsdorf shares her presentation on Rheumatoid Arthritis (RA) at The LDN 2018 Conference.

In this presentation Dr Zielsdorf presents a fascinating case study of a patient with Rheumatoid Arthritis (RA) detailing her experience with symptoms, statistics and her own wealth of medical experience.

Jill Cottel, MD - Treating the Zebras in Primary Care (2017 Conference) (LDN, low dose naltrexone)

In this presentation Dr Cottel shares case studies of patients:

36 year old woman with Ehlers-Danlos Syndrome. This lady was started on Low Dose Naltrexone (LDN) at 1.5mg, increased to 3 mg and found she lost her earlier improvement but on going down to a much lower dose she improved significantly. 

“Skip” Lenz, PharmD - Report on LDN Study (2016 Conference) (LDN, low dose naltrexone)

Download Dr. Lenz's LDN Study Presentation

“Report on the Longitudinal Study of the Effects, Side Effects & Interaction of Naltrexone in Low Dose”.